These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20831456)

  • 1. Opioid use and healthcare costs among patients with DPNP initiating duloxetine versus other treatments.
    Chen S; Wu N; Fraser K; Boulanger L; Zhao Y
    Curr Med Res Opin; 2010 Oct; 26(10):2507-16. PubMed ID: 20831456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid utilization and health-care costs among patients with diabetic peripheral neuropathic pain treated with duloxetine vs. other therapies.
    Wu N; Chen SY; Hallett LA; Boulanger L; Fraser KA; Patel CK; Zhao Y
    Pain Pract; 2011; 11(1):48-56. PubMed ID: 20602718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.
    Zhao Y; Sun P; Watson P
    Curr Med Res Opin; 2011 Apr; 27(4):785-92. PubMed ID: 21303196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain.
    Wu N; Chen S; Boulanger L; Fraser K; Bledsoe SL; Zhao Y
    J Med Econ; 2009 Sep; 12(3):192-202. PubMed ID: 19705975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies.
    Zhao Y; Wu N; Chen S; Boulanger L; Police RL; Fraser K
    Curr Med Res Opin; 2010 Sep; 26(9):2147-56. PubMed ID: 20662557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.
    Zhao Y; Sun P; Watson P; Mitchell B; Swindle R
    Pain Pract; 2011; 11(3):204-16. PubMed ID: 20807351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    Wu EQ; Birnbaum HG; Mareva MN; Le TK; Robinson RL; Rosen A; Gelwicks S
    J Pain; 2006 Jun; 7(6):399-407. PubMed ID: 16750796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.
    Zhao Y; Liu J; Zhao Y; Thethi T; Fonseca V; Shi L
    Pain Pract; 2012 Jun; 12(5):366-73. PubMed ID: 21951753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of comorbid depression or anxiety on patterns of treatment and economic outcomes among patients with diabetic peripheral neuropathic pain.
    Boulanger L; Zhao Y; Foster TS; Fraser K; Bledsoe SL; Russell MW
    Curr Med Res Opin; 2009 Jul; 25(7):1763-73. PubMed ID: 19505204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectory analysis of healthcare costs for patients with major depressive disorder treated with high doses of duloxetine.
    Cui Z; Faries DE; Zhao Y; Novick D; Liu X
    J Med Econ; 2011; 14(5):662-72. PubMed ID: 21892857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine.
    Harnett J; Margolis J; Cao Z; Fowler R; Sanchez RJ; Mardekian J; Silverman SL
    Pain Pract; 2011; 11(3):217-29. PubMed ID: 21199319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care.
    Gore M; Tai KS; Chandran A; Zlateva G; Leslie D
    J Med Econ; 2012; 15(1):19-31. PubMed ID: 21970699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of healthcare resource utilization and costs in employees with pain associated with diabetic peripheral neuropathy treated with pregabalin or duloxetine.
    Margolis J; Cao Z; Fowler R; Harnett J; Sanchez RJ; Mardekian J; Silverman SL
    J Med Econ; 2010; 13(4):738-47. PubMed ID: 21091395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.
    Zhao Y; Chen SY; Wu N; Fraser KA; Boulanger L
    Pain Pract; 2011; 11(4):381-91. PubMed ID: 21199311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health care costs in patients with fibromyalgia on pregabalin vs. duloxetine.
    Burke JP; Sanchez RJ; Joshi AV; Cappelleri JC; Kulakodlu M; Halpern R
    Pain Pract; 2012 Jan; 12(1):14-22. PubMed ID: 21615857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.
    Chen S; Wu N; Boulanger L; Fraser K; Zhao Z; Zhao Y
    J Med Econ; 2011; 14(4):411-20. PubMed ID: 21615268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine use in employees with low back pain: treatment patterns and direct and indirect costs.
    Ivanova JI; Birnbaum HG; Kantor E; Schiller M; Swindle RW
    Pain Med; 2014 Jun; 15(6):1015-26. PubMed ID: 24529260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
    Skljarevski V; Desaiah D; Zhang Q; Chappell AS; Detke MJ; Gross JL; Ziegler D
    Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain.
    O'Connor AB
    J Pain; 2006 Nov; 7(11):867; author reply 867-8. PubMed ID: 17074629
    [No Abstract]   [Full Text] [Related]  

  • 20. The relationship between average daily dose, medication adherence, and health-care costs among diabetic peripheral neuropathic pain patients initiated on duloxetine therapy.
    Chen SY; Wu N; Boulanger L; Fraser KA; Zhao Y
    Pain Pract; 2010; 10(6):530-9. PubMed ID: 20412505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.